what is the average dose of semaglutide for weight loss (Wegovy) Treatment Obesity Expected Weight Loss for Semaglutide

The study findings suggest that clinicians may consider GLP-1 medications for those living with both type 2 diabetes and PAD, particularly individuals at higher risk

When used consistently under medical supervision, patients may lose up to 15% of their baseline weight

If you're interested in learning more or scheduling a consultation, don't hesitate to reach out to our office

doi: 10.3389/fneur.2023.1056341 Received 28 September 2022 Accepted 02 January 2023 Published 16 January 2023 Volume 14 - 2023 Edited by Jian-Quan Shi, Nanjing Medical University, China Reviewed by Tomas Marek, Mayo Clinic, United States

doi:10.1038/s41580-020-00313-x Dongoran RA, Mardiana M, Huang CY, Situmorang JH

Campforts B, Drukker M, van Amelsvoort T, Bak M